Renewal of medidata remote source review (RSR) annual subscription licenses for 70 studies. Includes services for 10 new studies builds and post go-live support for those studies. Options included for…

Ended Purchase Order Awarded Last action

Contract number
75N93024P00770
Awardee
Awarding agency
Obligated
$2,113,383

Award facts

Opportunity
Contract value 79% obligated
  • $2,113,382.98 Current, with exercised options
  • $2,668,651.03 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
513210 Software Publishers
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
New York, NY 10014, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00003 $638,076
Exercise an Option P00002 $72,000
Supplemental Agreement for work within scope P00001 $0
Original award $1,403,307

About this award

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2,668,651.03 firm-fixed price purchase order to Medidata Solutions, Inc., a foreign-owned, for-profit organization, to provide a 12-month renewal of Medidata Remote Source Review (RSR) software-as-a-service licenses and related services. The contract includes options to expand the number of licenses if required. This sole-source procurement is not set aside for small businesses. The award is associated with a larger indefinite delivery contract that Medidata holds with the National Cancer Institute valued at $74 million over five years, which provides comprehensive hosting, maintenance, and professional services for the Medidata Rave electronic data capture system. Medidata Solutions specializes in providing clinical trial management and remote monitoring software solutions to federal agencies, particularly within the healthcare and biomedical research sectors.

Description

Renewal of medidata remote source review (RSR) annual subscription licenses for 70 studies. Includes services for 10 new studies builds and post go-live support for those studies. Options included for additional subscription licenses, active study SU

Quick answers

Who was awarded contract 75N93024P00770?

75N93024P00770 was awarded to Medidata Solutions, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2024.

How much is contract 75N93024P00770 worth?

The government has obligated $2,113,383 on 75N93024P00770. Its potential value, with all options, is $2,668,651.

Was contract 75N93024P00770 competed?

The extent of competition for 75N93024P00770 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award